Esoteric Testing Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
The esoteric testing market is projected to experience a Compound Annual Growth Rate (CAGR) of 12.2% in the foreseeable future. During the COVID-19 crisis, the market faced notable challenges initially due to disruptions in supply chains and research for various drug projects. However, the adoption of esoteric testing methods in research and clinical trials has opened up substantial growth avenues for industry players. Although tests like flow cytometry initially saw a decrease in demand at the pandemic's onset, their significance surged later for assessing effective treatments and therapies, especially as the situation worsened. This trend is likely to persist, notably in evaluating the efficacy of COVID-19 vaccinations. For example, a specialized automated chemiluminescent immunoassay (CLIA) was developed to measure neutralizing antibody (NAb) levels for diagnosing SARS-CoV-2, determining treatments, and assessing vaccine effectiveness.
Additionally, the market's growth is being propelled by several factors, including the escalating cases of chronic, infectious, and rare diseases, alongside the expanding elderly population. The market is rapidly expanding due to the increased prevalence of chronic diseases and the development of tailored testing kits for specific therapeutic areas. According to a 2021 WHO report, it's projected that by 2030, one in every six individuals globally will be 60 years or older, with the number of people in this age group rising from 1 billion in 2020 to 1.4 billion by 2050. With the elderly population being more prone to genetic and chronic ailments, there will be a substantial surge in demand for esoteric tests in the coming years.
Comments
Post a Comment